A Bumper Week With Three Notable Exceptions: Rentokil, Chips and SpaceX
The UK results season has so far delivered another bumper week, with most companies beating or meeting expectations. The notable exception was Rentokil, one of the FTSE 100's biggest fallers this week after it published its half-year figures. On the Investors' Chronicle podcast, Julian Hofmann looked at what lay behind the pest control company's sharp share-price drop.
Outside the UK, the story was the retreat in many of the big artificial intelligence and semiconductor trades. Memory-chip makers SK Hynix and Samsung have been among the names to reverse course in recent weeks after a long run higher. That sell-off raises an obvious question for investors: where are the value opportunities in global markets now? Michael Fahy discussed his favourites on the show.
The episode also turned to SpaceX and the potential consequences of its IPO for British investors. The conversation was not about the paper losses investors may already be sitting on, but about whether the listing could be the first domino in opening up access to US IPOs for UK investors. Helen Kirrane explained the mechanics.
Taken together, the discussion points to a market in which domestic earnings season is still broadly healthy, but the momentum trades that led global equities higher are coming under pressure — and UK investors are looking for ways to participate in the next wave of US listings.
What the Rentokil Slide, AI Reversal and SpaceX IPO Chatter Mean
What Rentokil's Fall Says About UK Results Season
Rentokil's slide after its half-year numbers is a reminder that even in a broadly positive results season, individual large caps can disappoint. The podcast did not disclose the exact figures or the specific drivers behind the fall, so the precise mechanics are uncertain. In similar cases, a swing lower usually reflects a market that expected better organic growth, stronger margins or more reassuring guidance. What is clear is that one sharp decline does not define a full-year story; the next trading update will show whether the concerns were short-term or structural.
AI and Semiconductor Reversals: A Case for Global Value Hunting
The recent pullback in AI and semiconductor stocks, including memory-chip leaders SK Hynix and Samsung, marks a shift after a period when those names led global markets. Memory-chip manufacturing is inherently cyclical, so valuation depends as much on where the industry is in the cycle as on the long-term AI narrative. That is the context for Michael Fahy's value-hunting approach: rather than chasing momentum, he looks for companies in global and emerging markets whose share prices have fallen to levels not justified by earnings potential. The names he highlighted were not listed in the summary, but the logic is clear — sell-offs in leaders can create entry points for patient investors.
SpaceX, US IPOs and the Door Opening for UK Investors
Helen Kirrane's segment on SpaceX was framed around access rather than performance. The point, as summarised in the episode description, is that a successful SpaceX IPO could tip the first domino for UK investors' ability to take part in US listings. The episode does not detail the exact barriers to UK participation, but the implication is that access has historically been limited. If SpaceX does list and UK investors get a clear route in, it could encourage other high-profile US companies to follow and give British investors a broader menu of growth stocks. None of that is confirmed yet, and the timeline of any listing remains uncertain.
Practical Steps for Rentokil Holders, Global Value Hunters and UK IPO Watchers
- For Rentokil investors: benchmark the half-year release against management guidance when the next trading update lands; one post-results plunge does not tell you whether margins and organic growth are improving.
- For global equity investors: do not treat the SK Hynix and Samsung pullback as an automatic value buy — memory-chip earnings move with the cycle, so assess where capacity and demand sit before committing.
- For UK investors eyeing US IPOs: check now whether your broker would support a SpaceX-style US listing; access rules vary by platform, and waiting until the deal prices is too late.
- For value hunters: follow Michael Fahy's approach in the episode — screen global and emerging markets for quality companies whose share prices have fallen with the AI trade but whose earnings do not depend on AI momentum.
Risk & Opportunity Assessment
| Commercial Risk | Medium | Rentokil's sharp post-results decline suggests the market found something to dislike in its half-year figures, although the summary does not specify what. |
| Competitive Risk | Medium | The reversal in AI and semiconductor leaders such as SK Hynix and Samsung shows how quickly crowded momentum trades can unwind, cutting into recent sector leadership. |
| Regulatory Risk | Medium | A SpaceX IPO would test whether UK investors can participate in US listings under current rules, potentially prompting changes in platform access or regulation. |
| Reputation Risk | Low | No reputational incidents are identified in this episode, which centres on regular earnings and market themes. |
| Technology Disruption | Medium | The AI and semiconductor trade reversal is a reminder of the sector's volatility; memory-chip cycles and AI demand expectations could shift further. |
| Commercial Opportunity | Medium | The sell-off in global AI and semiconductor names, combined with the prospect of US IPO access, creates potential openings for value investors and UK platforms. |
Comments 0